enGene Holdings Inc Sustainability Reports
enGene Therapeutics Inc. operates as a clinical-stage biotechnology company developing non-viral genetic medicines. The company focuses on therapeutics delivered directly to mucosal tissues and other organs, primarily targeting urological cancers such as non-muscle invasive bladder cancer.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
LEI: 529900NE5JFN74BYXQ13
1 reports from 2024 to 2024
Company Profile
enGene Therapeutics Inc. operates as a clinical-stage biotechnology company developing non-viral genetic medicines. The company focuses on therapeutics delivered directly to mucosal tissues and other organs, primarily targeting urological cancers such as non-muscle invasive bladder cancer.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
